Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01488448 · ClinicalTrials.gov registry record · NA

A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis

A NA study of Bronchiolitis, sponsored by Montefiore Medical Center.

Completed
Registry status
NA
Development phase
227
Enrollment target
1
Study location

NCT01488448 is a NA study of Bronchiolitis that has completed, run by Montefiore Medical Center. The registered enrollment target is 227 participants, below the 558-participant average among 12 other Bronchiolitis trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01488448, a NA study of Bronchiolitis, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
NA
Development phase
227 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if nebulized hypertonic saline (or extra salty water mist) helps infants less than 12 months old hospitalized with bronchiolitis (or bad chest colds) get better enough to be discharged from the hospital sooner than those infants given nebulized normal saline (or regular salty water mist).

Conditions Studied

Interventions

  • DRUG 0.9% sodium chloride
  • DRUG 3% sodium chloride

Study Locations (1)

New York

  • Children's Hospital at Montefiore - The Bronx

Trial Details

FieldValue
Enrollment Target 227 participants
Start Date 2011-11
Est. Completion 2015-08
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT01488448

The ClinicalTrials.gov registry entry for NCT01488448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 558-participant average among 12 other Bronchiolitis trials with a reported enrollment target (59% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bronchiolitis appearing as the primary indexed condition, and to 2 interventions - of which 0.9% sodium chloride is the first listed.

NCT01488448 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01488448 about?

NCT01488448 is a clinical study titled "A Study of Hypertonic Saline for Infants Hospitalized With Bronchiolitis". The purpose of this study is to determine if nebulized hypertonic saline (or extra salty water mist) helps infants less than 12 months old hospitalized with bronchiolitis (or bad chest colds) get better enough to be discharged from the hospital sooner than those infants given nebulized normal saline...

What is the current status of trial NCT01488448?

This trial is currently completed. It is a NA study. The enrollment target is 227 participants. The study started on 2011-11. Estimated completion is 2015-08.

What conditions does trial NCT01488448 study?

This clinical trial studies the following conditions: Bronchiolitis.

What interventions are being tested in trial NCT01488448?

The interventions under investigation include: 0.9% sodium chloride (DRUG), 3% sodium chloride (DRUG).

Who is sponsoring clinical trial NCT01488448?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01488448 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchiolitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.